A Biosensor Could Improve Lip and Oral Cavity Cancer Diagnosis
https://pixabay.com/en/bioreactors-glass-anaerobic-chamber-1781344/

A Biosensor Could Improve Lip and Oral Cavity Cancer Diagnosis

In multiple disease states, early identification, diagnosis, and treatment can significantly improve overall survival rate and patient outcomes. This is especially true for lip and oral cavity cancer. According to…

Continue Reading A Biosensor Could Improve Lip and Oral Cavity Cancer Diagnosis
MuSK-CAART for MG Earns Fast Track Designation
source: pixabay.com

MuSK-CAART for MG Earns Fast Track Designation

Currently, there are few effective therapeutic options for patients with MuSK antibody-positive myasthenia gravis (MG). A majority of those with MG have autoantibodies targeting the acetylcholine receptor. As a result, acetylcholinesterase…

Continue Reading MuSK-CAART for MG Earns Fast Track Designation
Family Raises SCA3 Awareness
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

Family Raises SCA3 Awareness

The Klassen family is no stranger to the rare disease community. According to the Denver Post, Greg Klassen was first diagnosed with spinocerebellar ataxia type 3 (SCA3) nearly ten years…

Continue Reading Family Raises SCA3 Awareness
How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19
source: pixabay.com

How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19

From social distancing and shuttered businesses to personal health concerns, COVID-19 has changed daily life for the foreseeable future. There are nearly 4.75 million diagnoses worldwide, with 1.53 million in…

Continue Reading How Rare Disease Biotech “Cure Rare Disease” Is Handling COVID-19